Home > Cashflow Statement > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
Cashflow Statement

SAMRAT PHARMACHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SAMRAT PHARMACHEM
Please provide your vote to see the results

SAMRAT PHARMACHEM Last 5 Year Cashflow Statement History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax₹2.52 Cr₹23 Cr₹24 Cr₹7.34 Cr₹5.79 Cr
Adjustment ₹0.03 Cr₹1.65 Cr₹1.19 Cr₹1.70 Cr₹1.39 Cr
Changes In working Capital ₹9.27 Cr₹-24 Cr₹-5.78 Cr₹-1.99 Cr₹-7.62 Cr
Cash Flow after changes in Working Capital ₹12 Cr₹0.06 Cr₹19 Cr₹7.05 Cr₹-0.45 Cr
Cash Flow from Operating Activities ₹9.41 Cr₹-9.44 Cr₹17 Cr₹4.80 Cr₹-1.33 Cr
Cash Flow from Investing Activities ₹-0.41 Cr₹-3.00 Cr₹-1.06 Cr₹-2.92 Cr₹-1.92 Cr
Cash Flow from Financing Activities ₹-11 Cr₹9.60 Cr₹-1.95 Cr₹-1.89 Cr₹2.00 Cr
Net Cash Inflow / Outflow ₹-2.19 Cr₹-2.84 Cr₹14 Cr₹-0.02 Cr₹-1.25 Cr
Opening Cash & Cash Equivalents ₹12 Cr₹15 Cr₹0.24 Cr₹0.26 Cr₹1.50 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹9.67 Cr₹12 Cr₹15 Cr₹0.24 Cr₹0.26 Cr

Compare Cashflow Statement of peers of SAMRAT PHARMACHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM ₹106.0 Cr -11.2% -18.4% -17.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,936.0 Cr -5.8% -3.2% 35.1% Stock Analytics
DIVIS LABORATORIES ₹152,157.0 Cr -2.8% -3.6% 44.7% Stock Analytics
CIPLA ₹116,200.0 Cr -3.9% -0.5% 13.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,325.0 Cr -1.2% 7.1% 17.8% Stock Analytics
ZYDUS LIFESCIENCES ₹98,037.4 Cr -2.7% -0.1% 40.9% Stock Analytics


SAMRAT PHARMACHEM Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM

-11.2%

-18.4%

-17.5%

SENSEX

-2.1%

-6.4%

7%


You may also like the below Video Courses